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 CD4+ T cells are imperative in the immune response to infections, but the immune response to 
malaria, especially in young children, is poorly understood, due to a lack of a young rodent animal model 
to study the pathogenesis of the disease. In this thesis, we focused on developing, a young mouse (pup) 
malaria model to help understand the immune response and development of protective CD4+ T cells. 
Using day 14-17 old pups, we are able to replicate childhood malaria in mice. We demonstrate that pups 
suffer severe malaria that results in decreased scores on behavioral and neurological tests. Malaria also 
induced stunted growth in the infected pups and a 60% mortality. There was no significance difference in 
cytokine production in memory cells between pups that were re-infected and adult mice. Upon transfer of 
immune splenocytes into immunocompromised RAGKO mice, mice that received pup cells looked 
healthier and active throughout the experiment, compared to their adult cell recipient counterparts. Mice 
that received adult cells also lost more weight than the pup cell recipients. There was no difference in 
both central and effector memory CD4+ T cell subsets at day 60 post-infection in the RAGKO mice, but 
the adult cell recipients had significantly more IFN- and TNF. These data suggest that pup cells protect 
immunocompromised mice from death, but do not develop well into functional memory in chronic 
infection. Finally, we demonstrate that pup splenocytes proliferate faster than adult cells, when stimulated 
in vitro by plate bound anti-CD3/CD28, as measure by CFSE dilution. But purified CD4+ T cells from pups 
spleens proliferate slower compared to CD4+ T cells from the adult mice. This suggests that there is yet 
to be described immune population in the pup splenocytes that is protective and proliferate better than the 
CD4+ T cells. Therefore, future studies will determine other immune cells other than CD4+ T cells that 
could be protective in young mice. These studies will open avenues for vaccine design for this deadly 
malaria disease and other chronic infections. 
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CD11b+: Surface marker for macrophage cells that phagocytose parasites 
CD4+ T cells: Helper T cells that regulate immune response 
iRBCs: infect red blood cells 
RAGKO: Recombinant activation gene knockout mice  
Sporozoite: a motile stage of the parasite Plasmodium falciparum  
IFN- (interferon gamma): Inflammatory cytokine important activator of macrophages  
CD8+ T cells: Cytotoxic T cell subset that kills cells are that infected  
Interleukin 12 (IL-12): Important cytokine for T helper 1 differentiation 
Tumor necrosis factor (TNF): Inflammatory cytokine produced by T helper 1 cells 
Interleukin 10 (IL-10): Anti-inflammatory cytokine protective in malaria 
Interleukin 6 (IL-6): Acts as both a pro-inflammatory cytokine  
Gamma Delta T Cells ( T cells): A type of T cell with a distinctive T-cell receptor found 











 According to the World Health Organization, malaria accounted for 445,000 deaths in 
2016, of which 70% occurred in children under the age of 5 [1]. Although there are four strains 
of malaria that affect humans, Plasmodium falciparum is the deadliest strain, accounting for 
90% of the world’s malaria cases and 91% of malaria deaths [1, 2]. Children who have 
contracted malaria show symptoms of high fever accompanied by chills and headaches [3]. 
Many children in Africa also suffer stunted growth due to malnutrition and malaria [4, 5, 6]. 
Children suffer from severe malaria the first time they contract the disease compared to adults 
that are asymptotic due to multiple infections throughout their life [2]. Other symptoms 
presented are diarrhea, weakness, abdominal pain, myalgia, and pallor, which can frequently be 
misdiagnosed as a viral syndrome or acute gastroenteritis [3]. Severe disease in children also 
leads to behavioral and neurological changes during  malaria infection [7]. Some of the 
neurological effects are coma, altered state of consciousness and severe metabolic 
derangement [7]. For children who receive adequate treatment, the fatality rate is lower than 
those children who live in rural areas where access to hospitals are limited. Although there have 
been improvements in the survival rate for children between 2010 to 2016, malaria continues to 
claim the life of one child every 2 minutes [1]. 
 Currently the focus for eradicating malaria is to decrease the amount of cases malaria 
first before eradication efforts begin. The major control efforts currently in place are long-lasting 
insecticidal nets (LLINs), indoor residual spraying (IRS), and treatment with artemisinin-based 
combination therapy (ACT) [8]. WHO recommends that for prevention of malaria, children of 5 
years and lower should use LLINs [9]. If a child has contracted malaria the only pediatric 
recommended medicine by WHO is ACT [9]. Long lasting insecticidal nets were first used in 
rural Kenya starting in the 1980s, but since the mid-2000s there has been a resurgence of 
malaria cases among communities with high ownership of LLINs [10]. This could be due to the 
emergence of resistance to the insecticide and improper use of ITNs. In South-East Asia there 
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are now accounts for malaria being resistant to ACT [11]. Although ACT shows effectiveness 
with Plasmodium falciparum, there is concern that there may  be development of resistance to 
this drug as reported in South-East Asia. 
 Geography has played a crucial role in helping eradicate malaria by mapping mosquito 
breeding sites near human habitats. By knowing where a large mosquito breeding site is 
located, governments can determine where to distribute drugs and insecticide-treated bed nets 
[12]. Model-based geostatistical methods and Geographic Information System (GIS) are major 
techniques used to map malaria. Geographers are trying to predict how malaria will spread with 
climate change by looking at variables such as temperature and rainfall. The current findings 
predict that with warmer temperatures and more rainfall, a larger proportion of the world’s 
population will be at risk of malaria [12]. With the rising temperatures throughout the world, 
geographers have started to focus on mapping wetlands, as they can facilitate malaria 
transmission by safeguarding mosquitos during dry seasons [13]. With the rising temperatures 
throughout the world, geographers are focusing on mapping wetlands, as they can assist 
malaria transmission by allowing the mosquito to lay larvae in water during dry seasons [14]. By 
mapping locations of wetlands and their proximity to human habitats this can help identify 
places that require a larger amount of eradication efforts due to the wetlands containing a large 
amount of Anopheles. 
  The life cycle of malaria begins when the female Anopheles mosquito injects 
Plasmodium sporozoites into the skin of a human. The sporozoites then migrate to the liver, 
where they grow in the hepatocytes, rupture the hepatocytes and enter the bloodstream, 
causing anemia and eventual death if the patient is not treated. Using rodent models of malaria, 
scientists have shown that within the first 15 minutes, some Plasmodium sporozoites begin the 
migration from skin to the liver. This process can last up to a few hours [15]. If sporozoites do 
not transverse through the dermis to the liver quickly, they are  trapped in the dermis and 
removed by CD11b+ phagocytic macrophage cells [16].   
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 Upon reaching the liver, the parasite can be eliminated by CD8+ cytotoxic T cells which 
kill the infected hepatocytes [15, 17, 18]. If the sporozoites survive and make it to the blood, then 
CD4+ T cells play a major role in producing cytokines such as IFN- and IL-12, that facilitate 
differentiation of CD4+ T helper cells to help in eliminating the parasite by producing more 
proinflammatory cytokine including  interleukin (IL)-12, tumor necrosis factor  alpha (TNF) and 
interferon gamma (IFN-) [17, 19-24]. This helps to limit the progression of malaria from 
becoming severe. However, if the immune system produces too much TNF, this could result in 
increased pathology. One study reported lower amounts of IL-12 and IFN- in African children 
suffering from severe malaria, compared to those with mild malaria [25]. A child suffering from 
severe malaria or anemia had a higher amount of TNF and IL-10 detected in their blood [25]. 
In another study, a child that succumbed to the disease was found to have a higher amount of 
IL-6, IL-10, and TNF in their blood compared to those who survived [26]. This suggests that 
malaria infection induces production of a variety of cytokines. 
 Most human hosts who are infected with malaria survive the acute infection. However, 
they are considered to be chronically infected afterwards due to the inability of the host body to 
produce a sizable immune population without repeated infections [27]. Plasmodium falciparum 
is able to elude the immune system by changing the expression of certain surface proteins [28]. 
The parasite has around 60 var genes, which allows it to maintain the chronic stage of the 
infection [29]. If the parasite only expressed one to five var genes, then the immune system 
would be able to eliminate the it [29].  However, as the immune system does this, it weakens its 
response against erythrocyte membrane protein (pfEMP1) proteins, which are found on the 
infected red blood cells [29]. This allows the parasite to live longer causing chronic stage 
malaria in the host. To evade the immune system is the  infection erythrocytes can also 
cytoadhere in human endothelium, this is why pfEMP1 has been identified as key towards 
humoral immunity [30, 31].  
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 The proposed vaccine for malaria is the RTS,S/AS01E, which is in the fourth stage of 
clinical trial. This vaccine candidate targets the pre-erythrocytic cycle of Plasmodium falciparum 
in humans because this stage allows the parasite to avoid the immune system [32]. 
RTS,S/AS01E halts the life-cycle of the parasite in the pre-erythrocytic phase, and therefore 
blood stage malaria does not occur. A recent trial of RTS,S/AS01E in infants showed the 
vaccine to be 65% effective [33]. However, young children between the ages of 3 to 5 years old, 
who engage in more outside play time, are at greatest risk of contracting malaria, but the 
vaccine has yet to be tested on children at this age. One paper contradicted most studies and 
argued that the effect of the vaccine was not as apparent or significant when adjusting for 
previous episodes of malaria, such as the child acquiring natural immunity from contracting the 
disease [30]. 
 Most of what is known about malaria is based on an adult mouse model, there has yet to 
be a mouse model that mimics malaria in children [2]. Despite these elegant studies, malaria in 
children is understudied, and there is no established model for childhood malaria in mice. Lack 
of such a model limits progression of studies to understand the pathogenesis of malaria in the 
most susceptible population Thus, it is important to identify a pup model that reflects malaria in 
children. The studies in this thesis aimed to provide novel information and establish a timeline 
for childhood malaria using a C56Bl/6 mouse model. 
 
MATERIALS AND METHODS 
Parasite 
 Our experiment used the rodent strain of Plasmodium chabaudi chabaudi (AS). This 
parasite induces chronic malaria infections and imitates symptoms of human malaria induced by 
Plasmodium falciparum, such as anemia, weight loss and chronic infection. The parasite was 
provided to us by Dr. Robin Stephens (University of Texas Medical Branch), with permission 




Types of animals used and conditions 
 A breeding colony of wildtype (C57BI/6) mice were purchased from Charles River 
Laboratories (Wilmington, MA), and maintained in our animal facility at Appalachian State 
University, to produce young mice (pups) for the experiments. RAGKO (Rag1tm1Mom) mice were 
purchased from Jackson Laboratories (City, state), and a breeding colony was also maintained 
in the animal facility with filtered tops to avoid exposure to the environment as they are 
immunocompromised. RAGKO mice were used to determine if pup or adult splenocytes could 
protect RAGKO from death. Wildtype pups were used for experiment between days 14 - 17 of 
age, while wildtype adults and RAGKOs were at 8 to 12 weeks when infected with malaria for all 
experiments. The housing conditions for animals were maintained at a constant room 
temperature with 12 hour light and dark cycles. The animals were allowed free access to water 
and food at all times. The experiments performed on the mice are described below and mice 
were euthanized with isoflurane or pentobarbital. All experiments were carried out in 
accordance with the protocols approved by The Institutional Animal Care and Use Committee 
and The Appalachian State University Institutional Biosafety Committees. 
 
Techniques Used 
Flow cytometry surface staining 
 Spleens were collected from mice and placed in labeled tubes filled with Iscove’s 
Modified Dulbecco’s Medium (IMDM). The spleens were mashed through a 70-micron mesh 
screen and then gathered back into the respective tubes. The tubes were spun at 1200 rpm for 
8 minutes, decanted and vortexed. Cells were then incubated for 2 minutes with red blood cell 
(RBC) lysis buffer to remove the RBCs. Lysis of RBC was stopped by addition of phosphate-
buffered saline (PBS) and centrifugation to pellet the remaining white blood cells. Cells were 
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resuspended in Iscove’s media and an aliquot was taken for counting at 1 to 100 dilutions in 
PBS and trypan blue to determine viable cells. After counting, 3 x106 cells were aliquoted into 5 
mL polystyrene tubes. One mL of florescent activated cell sorting (FACS) buffer was added to 
each tube and spun at 1200 rpm for 5 minutes. Cells were stained with 50 L of antibody 
cocktail containing CD4- fluorescein isothiocyanate (FITC), CD44- phycoerythrin (PE) and 
CD62L phycoerythrin-Cy7 (PE-Cy7) (Tonbo Biosciences, San Diego, CA), surface T helper 
markers to determine CD4 T cell activation status. The tubes were incubated on ice for 40 
minutes, then washed with FACS buffer. The cells were then re-suspended in 300 L of FACS, 
and filtered using cell strainers, and collected on a FC500 flow cytometer (Beckman Coulter Inc, 
Indianapolis, IN). Here we are measuring the amount of effector T cells, and memory-T cells.  
 
Flow cytometry intracellular cytokine staining 
An aliquot of 3 x 106 cells from each initial spleen tube was placed in a 24-well plate and 
incubated for 5 hours. Two additional wells were used as controls with one being an isotype 
control with stimulation and the other being a negative control without stimulation. After the 5 
hours incubation, the cells were harvested into 5 mL polystyrene tubes and washed with 1 mL of 
FACS buffer. The cells were stained with a cocktail of 50 L containing CD4- FITC, and 
incubated on ice for 40 minutes. After incubation, cells were washed in FACS buffer, and fixed 
by incubating in 2% paraformaldehyde (PFA) for 30 minutes. Cells were spun down and 
permeablized by addition of 1 mL of Perm-Wash buffer (Tonbo Biosciences) and 30 minutes 
incubation on ice. Cells were spun down and incubated for 20 minutes in Fc-block, before 
addition of a cocktail containing IFN--PE and TNF-PE-Cy7 (BioLegend, San Diego, CA,) 
antibodies, followed by a further 40 minutes incubation. Cells were then washed three times 
with Perm-Wash and resuspended in 300l then collected on a FC500 Beckman Coulter flow 
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cytometer. The samples were analyzed by FlowJo to determine proportions of IFN- and TNF 
in the splenocytes.  
 
SHIRPA 
  SmithKline Beecham, Harwell, Imperial College, Royal London Hospital, phenotype 
assessment (SHIRPA) was conducted to characterize the behavioral and neurological changes 
in pups during three stages with a series of individual tests that provide quantitative data about 
the pup’s individual performance. SHIRPA has previously been used to predict the severity of 
malaria disease in mice and the behavioral and neurological that are seen children [34]. Scores 
were determined based on descriptions in protocol for each task that was provided by the 
creator of SHIRPA. Two students were trained by the professor before the experiment began 
and were allowed to conduct the experiment by themselves once they received approval from 
the professor. Looking at a wide range of tests such as motor strength and neural control define 
the presence of specific deficits. When a pup showed a poor performance in locomotor test this 
reflected a muscular weakness due to a dysfunction in the central nervous system. The tests 
were run in a simple manner that allowed the mouse to rest for 10 minutes before the next task 
began. Transfer arousal is when the mouse is transferred quickly into a new environment with 
little to no human contact in order to observe the animal’s immediate reaction. A score of 5 
showed that the mouse did not freeze when transferred to the new environment while a lower 
score indicates a longer pause before moving.  As the mouse explores its’ new environment, the 
tail elevation is observed during the animal’s forward motion with a 2 showing the tail is 
elevated, a 1 indicating it is horizontally extended, and a 0 represents the tail is being dragged. 
The mouse was placed into a beaker for 5 minutes before body position was recorded. A score 
of 4 indicated the mouse was rearing on the hind legs, a 3 represent the mouse sitting, a 2 was 
lying prone and when the mouse was lying on its’ side it received a score of 1. While the mouse 
is being observed in a viewing jar the spontaneous activity of the mouse was observed with a 
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score of 3 showing that the mouse had a rapid and darting movement, a score of 2 showed 
vigorous grooming and moderate movement, 1 represented casual grooming or slow 
movement. When a mouse was resting or showed no movement it was given a score of 0. As 
the mouse was exploring the new environment the pelvic elevation was observed. If the pelvic 
region was more than 3mm in elevation the score of 3 was assigned, 2 represented a normal 
elevation of 3mm, 1 showed that the pelvic elevation was barely touching the floor and 0 was 
the pelvic flattened on the ground. For locomotor activity, a mouse was placed in an arena with 
equal lengths squares and a top was placed so the mouse would not run away. The number of 
times all four paws entered a square in 30 minutes was counted. Tremor was determined while 
the mouse was in the viewing jar. A score of 2 shows no tremor, a 1 represents that there was a 
mild tremor and a 0 show that an important tremor was observed. For negative geotaxis, the 
mouse was placed on a horizontal cage top and when the mouse moved in one direction the top 
was raised vertically so that the animal was facing the floor. A stopwatch was set for 30 seconds 
and the mouse was observed. A score of 4 showed that the mouse turned around and climbed 
up the grid, a 3 represents that although the mouse turned around it froze, when a mouse 
moved but did not turn around it was given a score of 2, 1 was given for the mouse that did not 
move for 30 seconds and 0 represents when the mouse fell off the grid. After a mouse had 
explored its’ new environment the mouse was stroked by a finger. When stroked if the mouse 
vigorously escapes the finger stroke it was given a score of 3, if the mouse had a rapid 
response to a light stroke it was given a score of 2, a score of 1 indicated that a firm stroke was 
required to get an escape response. For visual placing, the mouse was held by its’ tail and 
lowered to the cage top, and the extension of the forelimbs by the animal from a height of 15cm 
was observed. The score of 4 shows that the mouse had early vigorous extension around 
25mm above the cage top, 3 represents an extension of forelimbs before vibrasse contact 
around 18mm, 2 shows the extension of forelimbs occurred upon vibrasse contact, 1 represents 
it occurred upon nose contact and 0 shows that there was no response. For SHIRPA tests, The 
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error bars represent the standard errors of the mean (SEM). The ¼ denotes that one of the 4 
mice that died during the experiment died that day. ¾ denotes that on that day 3 of the 4 mice 
that died during the experiment died that day. A cross denotes that all the mice that died during 
the experiment had died. 
 
In vitro culture  
 Splenocytes and CD4 T cells were cultured in complete culture media comprising of 
IMDM, 10% FCS, 2mM L-glutamine, 5mM Sodium Pyruvate, MEM NEAA, 10mM HEPES, 100 
U/ml Penicillin, 100 U/ml Streptomycin, 2 mM of 2 microMercaptoethanol. A 24 well plate was 
coated with a cocktail of 100 mL of 1 g/ml of anti-CD3 and anti-CD28 solution and incubated 
overnight at 4oC in the fridge. On day 2, single cells suspensions were collected from the 
spleens of naïve day 14 pups or 8 weeks old adult mice using the normal procedure. The CD4+ 
T cells were purified using the EasySep CD4 purification kit according to the manufacturer’s 
instruction (StemCell Technologies, Vancouver, Canada). Cells were incubated in Rat Serum 
for 10 minutes followed by addition of CD4 Isolation Cocktails. The tubes were then incubated 
for 10 minutes and vortexed for 30 seconds afterwards. RapidSpheres were added to the 
samples and then incubated for 2.5 minutes. The volume in the tubes was adjusted then placed 
into the magnet for a 5 minute incubation. Both enriched cell suspension and spenocytes were 
stained with Carboxyfluorescein succinimidyl ester (CFSE) and counted. An aliquot of 1 x 106 
cells were placed into designated wells for culture. The cell culture plate was placed into a 37oC 
incubator supplemented with 5% CO2. Flow cytometry was performed on the cells at days 0, 2 
and 4 to examine proliferation status of both CD4 T cells and splenocytes from the two groups. 
 
Statistical analysis 
 Prism was used to statistically analyze the charts and graphs. A two-tailed t-test was 
performed for comparisons and signified with a * if there was significance. When no significance 
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was found NS was used to represent this. A ¼ or ¾ signified when deaths occurred of the 4 that 
occurred during SHIRPA. A cross symbolizes that all mice from the group had past.  
 
Experimental Design 
Monitoring progressive growth of healthy pups. 
 This project first looked at the growth pattern of pups without malaria infection. We 
weighed the pups starting at day 10 and continued to record the weights until they were 70 days 
old. This experiment included multiple litters of various sizes to calculate an average growth rate 
of both male and female pups. 
 
How does malaria infection affect the health and growth kinetics of young mice?  
 This analysis used pups that were 15 days old and were infected with 1x106 iRBCs, 
through the peritoneum. This experiment was carried out for 60 days post infection with blood 
being collected every day from day 8 to day 30 and at day 60. Survival and growth rate of 
infected pups and control adults were determined by calculating new weight minus the old 
weight divided by the old weight times 100 to get a percentage. SHIRPA was conducted on 
these mice to determine neurological and behavioral deficits between the infected pups, adults 
and the uninfected controls. The SHIRPA technique is described above. Once euthanized, flow 
cytometry was used to collect data, which was analyzed using the FlowJo software.  
 
Does malaria infection affect functionality of memory cells after pups grow to adulthood? 
 After the successful infection of pups and replication of stunted growth and mortality 
seen in humans, some experiments where the pups survived the first infection were re-infected 
at day 60 post infection to look at memory cells. We re-infect mice to observe the difference in 
activation of memory cells from pups that were previously infected to mice that have never been 
infected. The now adults and older adults were infected with 1x105 iRBCs and euthanized 7 
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days later to look at cytokine production. Data was collected by flow cytometry and analyzed 
using the FlowJo software. 
 
How does malaria infection affect activation and functionality of effector cells in pups? 
 To address this question, an experiment was conducted to determine the phenotype and 
cytokine secretion by CD4+ T cells during the peak of the infection.  Day 15 pups and 8-week-
old adults were infected and euthanized at day 8 post infection. Cells were collected from the 
spleens, processed using FACS protocol, and analyzed using flow cytometry and the FlowJo 
software.  
 
Can splenocytes from pups protect immunocompromised mice? 
 Day 15 pups and 8-week-old adults were infected with 1x105 iRBCs. At 8-day post 
infection, the pups and adults were euthanized, and spleens were collected. Single cell 
suspensions were obtained by mashing the spleens through a mesh screen and plunger, and 
red blood cells were lysed using the red blood cell lysis buffer (Tonbo Biosciences, CA). The 
spleen cells, (splenocytes) were transferred into RAGKO mice the same day. The next day, the 
RAGKO mice were infected with a lethal dose of malaria. The recipient mice were then 
monitored and weighed for 60 days.  Blood smears were collected until day 30 post infection for 
parasite counting. Percent weight change was calculated to determine the effect of malaria 
infection on host mice upon receiving pup or adult cells. On day 60 post-infection, the recipient 
mice were sacrificed, and phenotype and functionality of the donor cells were determined using 
flow cytometry and FlowJo.  
 
Are pup cells defective in their ability to proliferate? 
 This in vitro experiment was designed to test the difference in proliferation capability of 
pup and adult CD4+ T cells and all splenocytes after observing that the RAGKO recipients of 
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pup cells did not lose as much weight as adults’ recipients, but they survived through day 60 
post-infection. The cells were cultured in vitro to determine how well they proliferate at day 2 
and day 4. The technique of in vitro is described above.  
 
RESULTS 
Plasmodium chabuadi infection leads to stunted growth in infected young mice 
 To understand the effect of malaria on growth of young mice, we first determined the 
kinetics of growth in uninfected young mice by looking at a litter of pups starting on day 10 post 
birth. Both male and female pups progressively gained weight up to day 60, when the weights 
began to level of (Figure 1A). Based on recent studies comparing mice and human ages, it was 
determined that 2.60 days old pups would represent human ages 1 year. Therefore, we 
reasoned that 5-7 year old humans would be represented by young mice age range of 14 days 
to 17 days post birth [35].  We then infected 15 day old pups and 8 weeks old control adult mice 
to look at their response to malaria. Of the young mice that were infected, there was a dramatic 
decrease in weight gain compared to the uninfected control littermates. The dramatic decrease 
in weight gain occurred between days 9 to 14 post-infection (Figure 1B). The drastic difference 
in weight gain in the young mice reflects stunted growth shown in children that live in malaria-
endemic areas [36]. The pups also had a higher parasitemia count than infected adults (Figure 
1D). Sixty percent of the infected pups also succumbed to the infection between days 24-26 
post-infection (Figure 1C). The young mice that survived the infection had decrease weight gain 
up to 6 weeks post-infection, but later caught up in growth with their uninfected control 
littermates. The 8-week old adults lost weight at the peak of infection but regained quickly 





Fig. 1. Malaria infected pups have a slower growth and some die. Day 14 pups or week 8 adult mice 
were infected with 105 P. chabaudi and weights were taken over time. (A) Weight of control pups 
from day 10 to day 70 post birth (B) Weights over 9 weeks after infection. (C) Show parasitemia 
counts for pups and adults from day 5 to day 20. (D) Survival curve of pups and adults after infection 
with malaria. 
 
Malaria infected pups experience severe disease compared to infected adult mice  
 To understand how malaria affects the behavior of pups, we conducted SHIRPA on 
infected young mice and adults. Day 16 old pups and 8-week-old adult mice were infected with 
1x105 iRBCs, then a cognitive and behavioral test was conducted each day starting at the peak 
of infection. We observed a difference in the pups who died from malaria compared to those 
that survived the infection. Infected pups that died (IFD) had lower scores in tests such as body 
position, spontaneous activity and tremor compared to infected pups that survived (IFS) and the 
control pups that were not infected (CP) (Figure 2A, 2B, 2C). Although the IFD began to 
recover, after day 11 post-infection,  they once again began to decline at day 13, while IFS and 
CP remained constant (Figure 2A, 2B, 2C). Similar observations were seen in other tests such 
as transfer arousal, tail elevation, touch escape and pelvic elevation (Figure 3A, 3B, 3C, 3E).  
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 Using SHIRPA, we also examined neurological functions in pups after malaria infection. 
Neurological deficits are seen in human children, as malaria renders them docile with a febrile 
fever [37]. On days 9 and 10, IFD and IFS were averaging the same on locomotor activity test, 
as they only moved around in a small number of squares while the CP were active and moved 
in many squares. At day 11 we saw the difference in IFS and IFD squares counted. After day 10 
we observed that the IFS were now moving in the same number of squares as the CP, but the 
IFD never reached the same number of squares as the CP (Fig 3D). This is an important 
indicator because it shows that both IFS and IFD suffered severe disease, but IFS were able to 
recover to the level of the uninfected control healthy pups. This shows that the IFD suffered 
neurological deficits that hindered their ability to recover from the disease. These results are 
similar to what was found in the grip strength and visual placing test which determined the ability 
of the mouse to visualize the cage grid wire at 25mm, 18mm and 10mm away from the cage top 
(Figure 4A and 4B).  
We next determined the ability of mice to recognize their body positioning through the 
negative geotaxis and righting reflex tests. IFD is the only category that showed deficit in these 
tests. On both tests the IFD showed a decrease in performance compared to others on day 12. 
The IFD were able to recover to their IFS and CP at day 13 but afterwards decreased in their 
ability to perform this function again (Figure 5A and 5B). The IFD entered into a coma like stage 
the day that they died and were unable to perform either of the tasks by either falling off the grid 
or failed to right itself when on its back. These data suggest that pups that were infected with 
malaria suffered severe neurologic damage from the disease. 
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Fig. 2. Malaria infected pups suffer severe disease. Infected mice were placed in on an open 
platform and observed for (A) Body Position, (B) Spontaneous activity, and (C) Tremor during the 




Fig. 3: Malaria infected pups have decreased behavior. Infected mice were placed on an open 
platform and observed for (A) Transfer Arousal (B) Tail Elevation (C) Touch Escape (D) Locomotor 
activity (E) Pelvic elevation during the peak of infection through recrudescence, as described in the 





Fig. 4.  Infected young mice have impaired grip strength and vision. Mice were tested for their 
(A) grip strength and (B) ability to visualize the cage grid wire at 25mm, 18 mm and 10mm between 
peak infection and recrudescence, as described in the methods and materials section. 
 
 
Fig. 5.  Young mice that die have defective brain function. Mice were placed on a cage lid and 
(A) Negative Geotaxis was tested. Or mice were placed in a restricted container and turned upside 
down then (B) Righting reflex was determine between the peak of infection until recrudescence as 
described in the methods and materials section.   
 
Pup immune cells are stimulated in malaria infection 
 After the establishment of a successful infection in young mice, this model was used to 
study the immunology aspects of pup cells. Studies have suggested that children have a lower 
immune function than adults [38]. This may make them more susceptible to malaria than adults. 
To test the immune response to the infection between the pups and adults, we infected 8-week-
old adult and 15-day old young mice with 1x105 iRBCs to look at the activation status and 
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functionality of effector T cells at day 8 post-infection. When analyzing the splenocytes from 
pups and adults, there was a higher proportion of IFN- production by CD4 T cells in adults 
compared to pups (Figure 6A, 6B). There was no difference in TNF secretion. This data 
suggests that due to the lower amounts of IFN- producing CD4 T cells, the pups may not 
induce a robust immune response to the infection hence succumb to the disease.  
 
Fig. 6. CD4 T cells from adult mice produce more IFN-. Mice were infected and euthanized at 
day 8 post infection then cytokines were determined by ICS. (A) Plots of IFN- cytokine producing 
CD4 T cells in infected adults, Infected pups and uninfected pups. (B) Quantification of cytokine 
production in all the mice. 
 
Mice that were previously infected as pups show no defect in cytokine production 
   To determine if there was a functional defect in memory CD4+ T cells generated in 
pups, we infected day 14 pups and 8-week-old adult mice for 60 days for memory cells to 
develop. We then re-challenged the pups that survived the original infection and adult controls 
at day 60 with 1x105 iRBCs. We sacrificed the mice 7 days after the second challenge to 
determine cytokine production by the CD4 memory cells from these mice. We observed no 
significant difference in the total number of CD4 T cells at this time-point (Figure 7A). Looking at 
cytokine production, there was no significance difference between the two groups in the 
production of both IFN- and TNF (Figure 7B and 7C). This data suggests that there is no 




Fig. 7. There is no defect in cytokine production by memory cells in mice infected as pups. 
Adult and pup mice were infected at week 8 or day 15 of age. Mice were then infected on day 60 
and cytokine production was determined 7 days later. (A) Total CD4 T cell numbers. (B) Percent of 
CD4 T cells producing IFN-g and TNF-a and (C) Number of cytokine producing CD4 T cells after a 
secondary infection.  
 
Pup cells protect immunocompromised mice from death and weight loss 
 Since we observed lower cytokine production by the pup cells during the acute phase of 
infection, but similar cytokine production at the memory phase, we wondered if the effector CD4 
T cells from pups would protect immunocompromised RAG knockout (RAGKO) mice, that do 
not have any adaptive response immune cells. We therefore infected day 15 old pups and 8-
week-old adult mice with 1x105 iRBCs. At day 8 post-infection, we harvested the spleens, lysed 
red blood cells and transferred all the splenocytes into RAGKO mice. The RAGKO recipient 
mice were then infected the following day with a lethal dose of malaria. Two RAGKO control 
mice that did not receive any cells were also infected with Plasmodium chabaudi (Figure 8A). 
These control mice died 24 days post-infection. The mice that were given pup splenocytes 
looked healthier and active throughout the experiment compared to the mice given adult 
splenocytes. The mice given adult splenocytes lost more weight than the pup cell recipients 
throughout the experiment, which lasted 60 days post infection (Figure 8B). The adult cell 
recipients also had a higher amount of parasitemia than pup cell recipients (Figure 8C). At day 
60 post-infection, we euthanized the mice to determine the proportions and number of effector 
and central memory CD4+ T cells. Surprisingly, there were no differences in the effector and 
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central memory CD4 T cells in pup cells recipients compared to the adult cell recipients (Figure 
9A, 9B, 9C). 
 We therefore reasoned that the adult cells must be producing more inflammatory 
cytokines, which would explain the drastic weight loss suffered by the adult host mice 
throughout the infection. We therefore determined cytokine production at d60 post-infection in 
the two groups. As expected, there was a higher production of both IFN- and TNF- by the 
adult splenocyte recipients than pup splenocyte recipients (Figure 10A, 10B). By having a 
higher amount of IFN- and TNF in adult cell recipients this shows that adult cells were more 
functional than pup cells in this experiment.  
 
Fig. 8: RAGKO mice that receive adult cells loss significant weight compared to mice that 
receive pup cells.  Splenocytes were harvested from adults or pups on day 8 post-infection and 
transferred into RAGO. The recipient mice were infected, and weights were determined. (A) The 






Fig. 9. No difference in the effector and central memory CD T cells in pup cells recovered in 
RAGKO mice. Activation status of CD4+ T cells recovered on d60 post-infection was determined. 
(A) Total CD4 memory T cells in adult, pup and no cell recipients. (B) Numbers of CD4 effector 
memory T cells and (C) central memory T cells in recipient hosts.   
   
 
 
Fig. 10. Adult cells produce more inflammatory cytokines in immunocompromised animals. 
Spleen samples were harvested on day 60 post infection. (A). Plots quantification of IFN- (B) Plots 










 To better understand the functional ability of pup cells, we looked at the proliferation of 
both adult and pup cells. This experiment looked at the proliferation of immune cells upon 
stimulation in vitro. Cells were harvested from 14 days old pups and 8-week-old adult mice and 
stimulated in wells bound with anti-CD3 and CD28. CFSE levels were determined to observe 
cell proliferation. On day 4 post culture, pup splenocytes had more CFSElo cells, meaning that 
the cells had proliferated more than adults (Figure 11A). However, the pup CD4+ T cells were 
slower to proliferate than adult CD4+ T cells at day 4 (Figure 11B). We also noticed that we 
collected less pup CD4 T cells on day 2 and 4 than we did for adult cells. Taken together, these 
data suggest that while the immune CD4 T cell population in the pups proliferate slower, there is 
yet undefined cell population in the pup splenocytes that proliferate faster and could be 
responsible for malaria protection.  
 
Fig. 11. Pup Splenocytes proliferate more, while CD4 T cells proliferate slower. All spleen 
cells or purified CD4+ T cells were stimulated in vitro using anti-CD3 and CD28. CFSE dilution 
was measured to determine cell proliferation. Plots and graph showing CFSE dilution (A) 




 While there has been great advancement in our understanding of immunity to malaria, 
most of this knowledge has focused on adult mice. With malaria accounting for over 70% deaths 
in children of five and younger [1], there is an urgent need for a young rodent model to help 
understand the mechanisms of immune development in this patient population. In this study, we 
developed a young mouse model to study the pathogenesis of the disease and immunity to 
malaria in young children. To our knowledge, this is the first rodent model design that has the 
ability to replicate childhood malaria in young mice. Just like children infected with malaria, we 
observe stunted growth of mice infected with malaria, and a mortality rate of close to 60%. 
Therefore, our proposed model is one of the first to match symptoms in childhood malaria 
disease. 
  We found that when RAGKO mice were given pup spleen cells, they looked 
healthier and did not lose as much weight as the RAGKO mice that received adult cells. 
Interestingly, the adult cell recipients also had higher parasitemia. It has been reported that 
gamma delta T cells ( T cells), which are different from the conventional   T cells, are 
protective in malaria infection and are found in high quantities in younger animals than adult 
mice [39]. To fight off an infection, the  T cells must be primed to recognize antigens;  T 
cells on the other hand have the ability to recognize patterns of dysregulation and can 
immediately respond and kill the infected cell [40]. Ohteki et al., found that there was a higher 
amount of CD3+  T cells found in mice aged 2- 8 weeks old, but then declined afterward [39]. 
This could explain why immunocompromised mice that received pup cells performed better.  
 One characteristic of malaria infection is change in behavior and defects in motor 
neurons [41]. SHIRPA has been used previously as an indicator to predict the severity of 
malaria disease, and manifests behavioral changes seen in children with severe malaria 
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infection [34]. We therefore used this technique in this study to understand the neurological and 
behavioral aspects of malaria in our new mouse model. A difference in performance was noted 
between the pups that were infected and died compared to pups that survived. The pups that 
were infected and survived did decrease in their ability to complete the different tasks, but did 
recover compared to the pups that were infected and died. The pups that were infected and 
died reached a comatose status, which was a key sign that they were succumbing to malaria. 
With the compelling deficiencies in the SHIRPA test in infected baby mice, this suggests that 
malaria has the potential to affect neurological functions in young mice. Similar observations 
have been reported in humans, especially children that suffer from cerebral malaria [48]. Based 
on these observations, we propose that SHIRPA may be used as an indicator that malaria 
affects neurological functions in mice, and possibly predict those that will die. 
 One of our interesting observations was that pups are stunted when they are infected 
with malaria compared to pups that are never infected. Importantly, those that died never 
attained more than 30% growth rate compared to the uninfected controls or the pups that 
survived the infection. Pups require large amounts of transforming growth factors-beta (TGF-) 
to grow; however, TGF- is known to be immunosuppressive [42]. TGF- suppresses the 
immune system downregulating IL-2 proliferative signals, thus inhibiting normal T cells 
proliferation [43]. With an unusual amount of TGF-, this throws off the concentration of helper T 
cell subsets by favoring regulatory T cells (Tregs) [44]. Indeed, a recent study showed that 
Tregs are highly generated in young children infected with malaria [44]. This could be one 
explanation as to why the pups succumb to the disease more often than adults, as the 
inflammatory cytokines are inhibited by the effect of Tregs. 
 An intriguing result from our project was how pup splenocytes proliferated more than 
adult’s splenocytes, but the opposite was found for pup CD4 T cells, in comparison to adult 
cells. In future studies, we plan to explore the different populations of cells in the spleens of 
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pups that could be expanding faster than adults. It is possible that they could be innate immune 
cells, or a yet to be discovered innate like lymphocyte cell population. 
We will also investigate if this faster proliferation is associated with increased cytokine 
production in the spleens of the pups splenocytes. 
 While our young rodent model provides a good basis for studying malaria, we observed 
a high background of activated cells in our uninfected control mice. This is a caveat that affects 
the interpretation of our results on CD4+ T cell activation. One possible explanation for these 
results is that the air in the animal room was not filtered and the cages had no cover tops thus 
allowing mice to be exposed to open air. We also experience difficulty of consistency in infecting 
baby mice due to their small size. This resulted in some mice that were supposedly infected not 
showing signs of infection. Therefore, precision is critical when using this model for 
immunological studies. 
 We will also determine differences in the proportions and numbers of  T cells in the 
young mice. We will specifically investigate at what point these cells are most active, and their 
distribution in different tissues of malaria infected pups. Once we have determined the 
proportions of  T cells, we will next test their ability to protect immunocompromised RAGKO 
mice. As young mice require TGF for growth, we will evaluate if the TFG- induces anti-
inflammatory response thereby inhibiting the development of an effective immune system in 
pups infected with malaria. Such information will be important for vaccine designs that can 
overcome this hurdle in growing young mice. We were surprised by the ability of primed pup 
splenocytes to protect RAGKO. Therefore, we would like to determine the role that naïve 







 We believe that this pup model is the closest model of childhood malaria for mice in the 
current scientific community. This model replicates the survival rate of children and also shows 
the potential loss of neurological and behavioral functions that are found in cerebral malaria. 
Importantly, there is stunted growth in infected pups, a very common feature for children in 
malaria endemic areas. With this model that replicates malaria in children, scientists will be able 
to explore the mechanisms underlying the susceptibility of children to malaria disease. While we 
use malaria as our infection model, we believe that this model could be applicable to other 
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